Type
- (-) Australian public assessment report (AusPar) (69)
- Cancellation by sponsor (513)
- ARTG (460)
- Prescription medicine registration (44)
- Section 14, TGO91 consent (21)
- Prescription medicine decision summary (19)
- Designation or determination (9)
- Cancellation or suspension (7)
- Prescription medicine evaluation (1)
Sponsor content
69 result(s) found, displaying 31 to 40
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Adalimumab
-
Australian public assessment report (AusPar)Australian Public Assessment Report for BNT162b2 (mRNA)
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Gemtuzumab ozogamicin
-
Australian public assessment report (AusPar)New AusPAR for Vyndamax (tafamidis) and Vyndaqel (tafamidis meglumine) for the treatment of transthyretin amyloid cardiomyopathy
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Bevacizumab
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Ceftazidime/Avibactam
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Talazoparib (as tosilate)
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Lorlatinib
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Tofacitinib (as citrate)
-
Australian public assessment report (AusPar)Australian public assessment report for Crisaborole